Prelude Therapeutics Incorporated (PRLD)
Nasdaq: PRLD · Pharmaceutical Preparations · Wilmington, DE · filing with the SEC since 2016
Who runs Prelude Therapeutics Incorporated
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Vaddi Krishna
CEO. First filing Sep 2020, latest Feb 5, 2026, 10 filings in all.
Officers reporting now
7
of 22 people with a filing in the last fifteen months
Directors reporting now
15
30 people on the record since 2020
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Morris Charles Q | Chief Medical Officer | Apr 2026 | May 4, 2026 | none |
| Brusky Sean P. | Chief Business Officer | Mar 2026 | Mar 19, 2026 | none |
| Vaddi Krishna | CEO | Sep 2020 | Feb 5, 2026 | none |
| Lim Bryant David | CLO, CFO, Corp Sec. | Feb 2023 | Feb 5, 2026 | none |
| Combs Andrew | Chief Chemistry Officer | Sep 2020 | Feb 5, 2026 | none |
| Scherle Peggy | Chief Scientific Officer | Sep 2020 | Feb 5, 2026 | none |
| Huang Jane | President, CMO | Apr 2022 | Oct 7, 2025 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| 667, L.P. | director | Sep 2020 | Jun 10, 2026 | none |
| Babler Martin | director | Jul 2021 | Jun 10, 2026 | none |
| Baker Bros. Advisors (Gp) LLC | director | Sep 2020 | Jun 10, 2026 | none |
| Baker Bros. Advisors LP | director | Sep 2020 | Jun 10, 2026 | none |
| Baker Brothers Life Sciences LP | director | Sep 2020 | Jun 10, 2026 | none |
| Baker Felix | director | Sep 2020 | Jun 10, 2026 | none |
| Baker Julian | director | Sep 2020 | Jun 10, 2026 | none |
| Bonita David P | director | Sep 2020 | Jun 10, 2026 | none |
| Dorton Katina | director | Oct 2025 | Jun 10, 2026 | none |
| Friedman Paul A | director | Sep 2020 | Jun 10, 2026 | none |
| Sandor Victor | director | Sep 2020 | Jun 10, 2026 | none |
| Orbimed Advisors LLC | director | Sep 2020 | Apr 23, 2026 | none |
| Orbimed Capital Gp Vi LLC | director | Sep 2020 | Apr 23, 2026 | none |
| Orbimed Capital LLC | director | Sep 2020 | Apr 23, 2026 | none |
| Orbimed Genesis Gp LLC | director | Apr 2026 | Apr 23, 2026 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Kolchinsky Peter | 10% owner | Apr 2026 | Apr 28, 2026 | none |
| Ra Capital Healthcare Fund LP | 10% owner | Apr 2026 | Apr 28, 2026 | none |
| Ra Capital Management, L.P. | 10% owner | Apr 2026 | Apr 28, 2026 | none |
| Shah Rajeev M. | 10% owner | Apr 2026 | Apr 28, 2026 | none |
Earlier names on the record8, newest filing first
Dier Mardi · director · last filing Jun 2025Scherer Paul C · director · last filing Jun 2025Chardonnet Laurent · officer · last filing Mar 2024Morosini Deborah · officer · last filing Feb 2022Mauro David J · officer · last filing Oct 2021Pierce Christopher · officer · last filing Sep 2021Piper Brian · officer · last filing Aug 2021Neu Kelvin · director · last filing Sep 2020
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.